A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2009

Conditions

Hepatitis C

Interventions

DRUG

ABT-072

Capsule or powder drug substance from the capsule mixed in an alternative vehicle. For additional information refer to Arm Description.

DRUG

placebo

Capsule, or powder drug substance from the capsule mixed in an alternative vehicle. For additional information refer to Arm Description.

Trial Locations (1)

Global Medical Information, Abbott Park